Literature DB >> 26673511

The Susceptibility of Celiac Disease Intestinal Microbiota to Clostridium difficile Infection.

Masoumeh Azimirad1, Mohammad Rostami-Nejad2, Kamran Rostami3, Tahere Naji4, Mohammad Reza Zali2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26673511     DOI： 10.1038/ajg.2015.360

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  6 in total

Review 1.  Clinical practice. Antibiotic-associated diarrhea.

Authors:  John G Bartlett
Journal:  N Engl J Med       Date:  2002-01-31       Impact factor: 91.245

Review 2.  The role of infectious mediators and gut microbiome in the pathogenesis of celiac disease.

Authors:  Mohammad Rostami Nejad; Sauid Ishaq; David Al Dulaimi; Mohammad Reza Zali; Kamran Rostami
Journal:  Arch Iran Med       Date:  2015-04       Impact factor: 1.354

3.  Glucosylation of Rho proteins by Clostridium difficile toxin B.

Authors:  I Just; J Selzer; M Wilm; C von Eichel-Streiber; M Mann; K Aktories
Journal:  Nature       Date:  1995-06-08       Impact factor: 49.962

4.  Infections may have a protective role in the etiopathogenesis of celiac disease.

Authors:  Leeor Plot; Howard Amital; Ori Barzilai; Maya Ram; Nicola Bizzaro; Bizzaro Nicola; Yehuda Shoenfeld
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

Review 5.  Bacteriotherapy using fecal flora: toying with human motions.

Authors:  Thomas J Borody; Eloise F Warren; Sharyn M Leis; Rosa Surace; Ori Ashman; Steven Siarakas
Journal:  J Clin Gastroenterol       Date:  2004-07       Impact factor: 3.062

6.  Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment.

Authors:  Lara Bull-Otterson; Wenke Feng; Irina Kirpich; Yuhua Wang; Xiang Qin; Yanlong Liu; Leila Gobejishvili; Swati Joshi-Barve; Tulin Ayvaz; Joseph Petrosino; Maiying Kong; David Barker; Craig McClain; Shirish Barve
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240
  6 in total
  7 in total

1.  Risk of Clostridium difficile Infection in Patients With Celiac Disease: A Population-Based Study.

Authors:  Benjamin Lebwohl; Yael R Nobel; Peter H R Green; Martin J Blaser; Jonas F Ludvigsson
Journal:  Am J Gastroenterol       Date:  2017-10-31       Impact factor: 10.864

Review 2.  Berberine as a Potential Agent for the Treatment of Colorectal Cancer.

Authors:  Xi Jiang; Zhongxiu Jiang; Min Jiang; Yan Sun
Journal:  Front Med (Lausanne)       Date:  2022-04-28

3.  Mucosal healing and the risk of serious infections in patients with celiac disease.

Authors:  Louise Emilsson; Benjamin Lebwohl; Peter Hr Green; Joseph A Murray; Karl Mårild; Jonas F Ludvigsson
Journal:  United European Gastroenterol J       Date:  2017-04-24       Impact factor: 4.623

Review 4.  Role of gut microbiota in the pathogenesis of colorectal cancer; a review article.

Authors:  Somayeh Jahani-Sherafat; Masoud Alebouyeh; Sharareh Moghim; Hamed Ahmadi Amoli; Hajieh Ghasemian-Safaei
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018

5.  Prevalence of binary-toxin genes (cdtA and cdtB) among clinical strains of Clostridium difficile isolated from diarrheal patients in Iran.

Authors:  Masoumeh Azimirad; Fatemeh Naderi Noukabadi; Farhad Lahmi; Abbas Yadegar
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018

6.  The rate and importance of Clostridium difficile in colorectal cancer patients.

Authors:  Somayeh Jahani-Sherafat; Masoumeh Azimirad; Masoud Alebouyeh; Hadi Ahmadi Amoli; Parnian Hosseini; Hajieh Ghasemian-Safaei; Sharareh Moghim
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019

7.  Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome.

Authors:  Kaveh Naseri; Hossein Dabiri; Mohammad Rostami-Nejad; Abbas Yadegar; Hamidreza Houri; Meysam Olfatifar; Amir Sadeghi; Saeede Saadati; Carolina Ciacci; Paola Iovino; Mohammad Reza Zali
Journal:  BMC Gastroenterol       Date:  2021-07-14       Impact factor: 3.067
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.